The global liver cancer market was valued at USD 2.21 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 20.0% during the forecast period. Key factors driving market growth include the rising prevalence of liver cancer, increased healthcare spending, ongoing advancements in diagnostics and therapeutics, and the development of targeted therapies....
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek